apparently had his picture taken with a marijuana bong in hand just announced that he does not have enough evidence to prosecute the Olympian or anyone else who was present at the November party.
Richland County (S.C.) Sheriff
Leon Lott,
in a news release sent to reporters via e-mail, states that: “Having thoroughly investigated this matter, we do not believe we have enough evidence to prosecute anyone that was present at the November party.
Read the rest of this entry »

BRISBANE, Australia (AP) — An American doctor charged with manslaughter in Australia unnecessarily removed a man’s bowel, took out the wrong gland in a cancer operation, and let an elderly man die of internal bleeding, a prosecutor said Monday.
Courtroom observers at the pretrial hearing of Jayant Patel grimaced, shook their heads and gasped as prosecutor Ross Martin delivered his grim opening statement, accusing the doctor of deadly negligence Read the rest of this entry »

charged Robert Allen Stanford and three of his companies in an alleged fraudulent investment scheme.
Ltd., based in Antigua. The bank is the majority owner of Health Systems Solutions Inc. (OTC BB: HSSO), a health care technology company with Tampa roots. The bank owned 83 percent of Health Systems’ common stock as of Jan. 20, according to a filing with the SEC.
The SEC’s complaint, filed in federal court in Dallas, alleges that Stanford Read the rest of this entry »

To be more specific, the accusations build around Coca-Cola’s line of VitaminWater. The consumer group released a statement on Thursday saying that Coca-Cola “markets VitaminWater as a healthful alternative to soda by labeling its several flavors with such health buzz words as ‘defense,’ ‘rescue,’ ‘energy’ and ‘endurance.’” Moreover, the company says its drinks also reduce the risk Read the rest of this entry »

(Updates with analyst comment, share price)
LONDON, Nov 28 (Reuters) – AstraZeneca Plc (AZN.L:
,
,
,
) faces a
delay in getting a new infant lung drug from its recently
acquired MedImmune biotech unit to market in the United States.
The Anglo-Swedish drugmaker said on Friday it had received a
so-called “complete response letter” from the U.S. Food and Drug
Administration (FDA) asking for additional information on
motavizumab.
The move Read the rest of this entry »

Heart disease is the No. 1 killer of American women. One out of every four women will die of it each year, more than 250,000 from heart attacks alone. Yet, stop a woman on the street and she is unlikely to list heart disease as a concern. Likewise, few realize that more women than men die of heart disease or that signs and symptoms in women can be subtle—nearly two-thirds of women who die suddenly of a heart attack had no prior symptoms. Additionally, Read the rest of this entry »

Somerset Medical Center’s blood supply is critically low and its Blood Donor Program is appealing to members of the community to donate blood to ensure an adequate supply to meet its patients’ needs. All blood types are needed.
“Our blood supply is always hardest hit in the winter months” says Kathy Puder, director of Somerset Medical Center’s Laboratory. “As the cold and flu season begins, many of our regular blood donors are sick and unable to Read the rest of this entry »

Residents will cast a historic vote Tuesday on whether to buy almost 400 acres of the former Norwich Hospital property, a decision that could have a significant and lasting impact on the town.
“Now it’s do or die,” Preston Selectman Gerald Grabarek said Sunday. “There’s no going back anymore.”
After four years of work, and two once-promising development deals that collapsed, polls will be open from 6 a.m. to Read the rest of this entry »

FRIDAY, Feb. 6 (HealthDay News) — U.S. Supreme Court Justice Ruth Bader Ginsburg will face tough challenges following her surgery on Thursday for early-stage pancreatic cancer, experts say.
At this point, it’s not clear exactly what type of pancreatic cancer Ginsburg has, but the odds suggest pancreatic adenocarcinoma, which accounts for about 85 percent of all cases and is a far deadlier malignancy than neuroendocrine pancreatic cancer.
“The Read the rest of this entry »

Eli Lilly & Co. said Wednesday the Food and Drug Administration is withholding approval on the long-acting version of schizophrenia treatment olanzapine.
The FDA is not requiring additional studies and the company said it is preparing a risk evaluation and mitigation strategy, to be submitted in the near future.
“We cannot speculate on the timing of a potential decision, but remain confident that, if approved, the long-acting depot formulation Read the rest of this entry »